However, despite the reduction in EMMPRIN, with its known ability to induce VEGF and MMPs (15, 35), no parallel reduction in the serum levels of VEGF or MMP-9 occurred in the sera of RA patients (Figure 1). This evidence concerns the gene MMP9 and rheumatoid arthritis.